Atea Pharmaceuticals (AVIR) Institutional Ownership $3.17 -0.05 (-1.55%) Closing price 04:00 PM EasternExtended Trading$3.16 -0.01 (-0.32%) As of 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Atea Pharmaceuticals (NASDAQ:AVIR)CurrentInstitutional OwnershipPercentage86.67%Number ofInstitutional Buyers(last 12 months)48TotalInstitutional Inflows(last 12 months)$21.56MNumber ofInstitutional Sellers(last 12 months)26TotalInstitutional Outflows(last 12 months)$7.11M Get AVIR Insider Trade Alerts Want to know when executives and insiders are buying or selling Atea Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVIR Institutional Buying and Selling by Quarter Atea Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers116,443$348K0.0%-10.3%0.136% 5/28/2025 Strs Ohio105,500$315K0.0%N/A0.123% 5/21/2025 Acadian Asset Management LLC917,846$2.74M0.0%-1.6%1.073% 5/19/2025 Jane Street Group LLC102,607$307K0.0%+80.4%0.120% 5/16/2025 Goldman Sachs Group Inc.258,608$773K0.0%-17.1%0.302% 5/16/2025 Jacobs Levy Equity Management Inc.118,167$353K0.0%-69.8%0.138% 5/16/2025 Almitas Capital LLC715,005$2.14M0.7%-4.9%0.835% 5/14/2025 MetLife Investment Management LLC45,456$136K0.0%+22.6%0.053% 5/14/2025 Hsbc Holdings PLC201,233$604K0.0%+24.1%0.235% 5/14/2025 Wellington Management Group LLP304,530$911K0.0%+39.4%0.356% Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/13/2025 Aldebaran Capital LLC37,500$112K0.1%N/A0.044% 5/13/2025 American Century Companies Inc.162,861$487K0.0%+12.2%0.190% 5/13/2025 Russell Investments Group Ltd.54,902$164K0.0%+10,793.3%0.064% 5/13/2025 HighTower Advisors LLC75,088$225K0.0%+49.9%0.088% 5/12/2025 Nuveen LLC291,091$870K0.0%N/A0.340% 5/12/2025 Invesco Ltd.173,156$518K0.0%-12.0%0.202% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.30,087$90K0.0%-60.6%0.035% 5/9/2025 Deutsche Bank AG60,263$180K0.0%N/A0.070% 5/9/2025 Charles Schwab Investment Management Inc.607,882$1.82M0.0%-7.8%0.710% 5/9/2025 CM Management LLC500,000$1.50M1.5%+66.7%0.584% 4/30/2025 Peapod Lane Capital LLC452,060$1.35M1.5%+37.6%0.529% 4/29/2025 Bank of New York Mellon Corp203,116$607K0.0%-4.2%0.237% 4/8/2025 Rhumbline Advisers116,443$348K0.0%-10.3%0.136% 2/19/2025 Public Employees Retirement System of Ohio36,371$122K0.0%-30.2%0.043% 2/17/2025 Squarepoint Ops LLC50,750$170K0.0%+223.3%0.060% 2/17/2025 Two Sigma Investments LP285,921$958K0.0%-16.3%0.339% 2/17/2025 Two Sigma Advisers LP493,600$1.65M0.0%-15.2%0.584% 2/17/2025 Tang Capital Management LLC4,788,912$16.04M1.1%+3.9%5.670% 2/17/2025 Shay Capital LLC30,633$103K0.0%+72.5%0.036% 2/17/2025 ProShare Advisors LLC25,733$86K0.0%+31.5%0.030% 2/17/2025 Newtyn Management LLC580,000$1.94M0.3%+52.6%0.687% 2/17/2025 Millennium Management LLC22,506$75K0.0%N/A0.027% 2/17/2025 Jacobs Levy Equity Management Inc.390,899$1.31M0.0%-23.3%0.463% 2/17/2025 Graham Capital Management L.P.12,511$42K0.0%N/A0.015% 2/17/2025 D. E. Shaw & Co. Inc.256,083$858K0.0%+32.3%0.303% 2/17/2025 Bridgeway Capital Management LLC33,300$112K0.0%N/A0.039% 2/17/2025 Bank of America Corp DE73,441$246K0.0%+23.3%0.087% 2/17/2025 BNP Paribas Financial Markets96,433$323K0.0%N/A0.114% 2/17/2025 Ameriprise Financial Inc.86,169$289K0.0%-12.1%0.102% 2/17/2025 Almitas Capital LLC752,003$2.52M0.6%-45.7%0.890% The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more.2/14/2025 Jane Street Group LLC56,891$191K0.0%-38.4%0.067% 2/14/2025 Northern Trust Corp704,909$2.36M0.0%+2.5%0.835% 2/14/2025 RBF Capital LLC54,929$183K0.0%-63.0%0.065% 2/14/2025 Price T Rowe Associates Inc. MD73,883$248K0.0%+5.5%0.087% 2/14/2025 MetLife Investment Management LLC37,091$124K0.0%-17.9%0.044% 2/14/2025 Dimensional Fund Advisors LP977,470$3.27M0.0%+23.2%1.157% 2/13/2025 Marshall Wace LLP77,581$260K0.0%N/A0.092% 2/13/2025 Zacks Investment Management13,966$47K0.0%-41.7%0.017% 2/13/2025 Barclays PLC200,113$671K0.0%+13.0%0.237% 2/13/2025 Renaissance Technologies LLC1,216,600$4.08M0.0%+0.8%1.440% 2/13/2025 ADAR1 Capital Management LLC110,000$368K0.1%N/A0.130% 2/13/2025 Federated Hermes Inc.582,939$1.95M0.0%+1.9%0.690% 2/13/2025 Wells Fargo & Company MN45,391$152K0.0%+27.8%0.054% 2/12/2025 Geode Capital Management LLC1,916,786$6.42M0.0%-0.4%2.269% 2/12/2025 JPMorgan Chase & Co.409,259$1.37M0.0%+329.7%0.485% 2/11/2025 Vanguard Group Inc.4,666,854$15.63M0.0%-3.8%5.526% 2/11/2025 Intech Investment Management LLC35,989$121K0.0%+236.0%0.043% 2/10/2025 Connor Clark & Lunn Investment Management Ltd.76,352$256K0.0%+72.9%0.090% 2/7/2025 HighTower Advisors LLC50,087$168K0.0%N/A0.059% 2/7/2025 CM Management LLC300,000$1.01M0.9%+11.1%0.355% 2/7/2025 BML Capital Management LLC7,608,312$25.49M15.8%+14.4%9.008% 2/6/2025 Charles Schwab Investment Management Inc.659,527$2.21M0.0%+1.4%0.781% 1/30/2025 Rhumbline Advisers129,796$435K0.0%-2.5%0.154% 1/29/2025 Peapod Lane Capital LLC328,581$1.10M1.1%N/A0.389% 12/26/2024 JPMorgan Chase & Co.95,244$319K0.0%+106.1%0.113% 11/20/2024 Virtu Financial LLC29,491$99K0.0%N/A0.035% 11/19/2024 Barclays PLC177,077$593K0.0%+74.5%0.210% 11/16/2024 Geode Capital Management LLC1,924,773$6.45M0.0%-4.2%2.279% 11/15/2024 Barclays PLC177,077$593K0.0%+74.5%0.210% 11/15/2024 Zacks Investment Management23,940$80K0.0%N/A0.028% 11/15/2024 Wellington Management Group LLP221,562$742K0.0%-13.2%0.262% 11/15/2024 State Street Corp1,733,486$5.81M0.0%+0.7%2.052% 11/15/2024 Jacobs Levy Equity Management Inc.509,471$1.71M0.0%-9.8%0.603% 11/14/2024 Verition Fund Management LLC56,909$191K0.0%-13.7%0.067% 11/13/2024 FMR LLC6,618,297$22.17M0.0%+2.8%7.836% 11/13/2024 Dynamic Technology Lab Private Ltd11,178$37K0.0%N/A0.013% 11/12/2024 Charles Schwab Investment Management Inc.650,157$2.18M0.0%+8.5%0.770% 11/9/2024 Intech Investment Management LLC10,711$36K0.0%N/A0.013% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.44,157$148K0.0%N/A0.052% 11/5/2024 BML Capital Management LLC6,650,000$22.28M13.1%+4.3%7.877% 10/25/2024 China Universal Asset Management Co. Ltd.16,237$54K0.0%+64.1%0.019% 10/3/2024 SG Americas Securities LLC30,612$103K0.0%+117.9%0.036% 9/16/2024 Cubist Systematic Strategies LLC34,045$113K0.0%-63.8%0.040% 8/16/2024 Almitas Capital LLC1,290,187$4.27M1.8%N/A1.532% 8/15/2024 The Manufacturers Life Insurance Company34,886$115K0.0%+14.2%0.041% 8/14/2024 Cubist Systematic Strategies LLC34,045$113K0.0%-63.8%0.040% 8/14/2024 Marshall Wace LLP182,326$603K0.0%N/A0.216% 8/14/2024 ProShare Advisors LLC15,466$51K0.0%-21.4%0.018% 8/12/2024 Hsbc Holdings PLC158,109$518K0.0%-7.7%0.188% 8/9/2024 Renaissance Technologies LLC1,141,500$3.78M0.0%+1.6%1.355% The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more.8/9/2024 Dimensional Fund Advisors LP594,360$1.97M0.0%+55.2%0.706% 8/8/2024 American Century Companies Inc.125,169$414K0.0%+14.6%0.149% 8/6/2024 Acadian Asset Management LLC934,505$3.09M0.0%-2.9%1.110% 8/1/2024 Rhumbline Advisers137,598$455K0.0%-3.0%0.163% 7/29/2024 Principal Financial Group Inc.11,425$38K0.0%-55.0%0.014% 7/26/2024 Bank of New York Mellon Corp266,184$881K0.0%+11.1%0.316% 7/12/2024 SG Americas Securities LLC14,051$47K0.0%-50.1%0.017% 5/17/2024 Tidal Investments LLC21,472$87K0.0%N/A0.025% 5/16/2024 California State Teachers Retirement System7,707$31K0.0%-38.9%0.009% 5/16/2024 Jacobs Levy Equity Management Inc.672,984$2.72M0.0%+22.2%0.799% (Data available from 1/1/2016 forward) AVIR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVIR shares? During the previous two years, 81 institutional investors and hedge funds held shares of Atea Pharmaceuticals. The most heavily invested institutionals were BML Capital Management LLC ($25.49M), FMR LLC ($22.17M), Tang Capital Management LLC ($16.04M), Vanguard Group Inc. ($15.63M), Geode Capital Management LLC ($6.42M), State Street Corp ($5.81M), and Renaissance Technologies LLC ($4.08M).Learn more on AVIR's institutional investors. What percentage of Atea Pharmaceuticals stock is owned by institutional investors? 86.67% of Atea Pharmaceuticals stock is owned by institutional investors. Learn more on AVIR's institutional investor holdings. Which institutional investors have been buying Atea Pharmaceuticals stock? Of the 67 institutional investors that purchased Atea Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($6.77M), Almitas Capital LLC ($1.29M), Stonepine Capital Management LLC ($1.10M), Newtyn Management LLC ($510.80K), Peapod Lane Capital LLC ($452.06K), Dimensional Fund Advisors LP ($395.27K), and JPMorgan Chase & Co. ($363.04K). How much institutional buying is happening at Atea Pharmaceuticals? Institutional investors have bought a total of 14,913,628 shares in the last 24 months. This purchase volume represents approximately $49.21M in transactions. Which Atea Pharmaceuticals major shareholders have been selling company stock? Of the 34 institutional investors that sold Atea Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($2.04M), Stonepine Capital Management LLC ($880.49K), Almitas Capital LLC ($669.52K), Jacobs Levy Equity Management Inc. ($446.73K), Vanguard Group Inc. ($184.36K), Acadian Asset Management LLC ($165.83K), and Cubist Systematic Strategies LLC ($120.16K). How much institutional selling is happening at Atea Pharmaceuticals? Institutional investors have sold a total of 5,413,302 shares in the last 24 months. This volume of shares sold represents approximately $17.05M in transactions. Related Companies CureVac Major Shareholders Mineralys Therapeutics Major Shareholders Phibro Animal Health Major Shareholders Arcus Biosciences Major Shareholders Wave Life Sciences Major Shareholders Syndax Pharmaceuticals Major Shareholders Collegium Pharmaceutical Major Shareholders Enliven Therapeutics Major Shareholders Spyre Therapeutics Major Shareholders Nurix Therapeutics Major Shareholders This page (NASDAQ:AVIR) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
